Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hepatology. 2012 Nov;56(5):1688-98. doi: 10.1002/hep.25866. Epub 2012 Oct 14.
Hepatitis C virus (HCV) infection has been associated with reduced bone mineral density, but its association with fracture rates is unknown, particularly in the setting of human immunodeficiency virus (HIV) coinfection. Our aims were to determine whether persons with HCV infection alone are at increased risk for hip fracture, compared to uninfected individuals, and to examine whether the risk of hip fracture is higher among HCV/HIV-coinfected persons, compared to those with HCV alone, those with HIV alone, and those uninfected with either virus. We conducted a cohort study in 36,950 HCV/HIV-coinfected, 276,901 HCV-monoinfected, 95,827 HIV-monoinfected, and 3,110,904 HCV/HIV-uninfected persons within the U.S. Medicaid populations of California, Florida, New York, Ohio, and Pennsylvania (1999-2005). Incidence rates of hip fracture were lowest among uninfected persons (1.29 events/1,000 person-years), increased with the presence of either HIV infection (1.95 events/1,000 person-years) or HCV infection (2.69 events/1,000 person-years), and were highest among HCV/HIV-coinfected individuals (3.06 events/1,000 person-years). HCV/HIV coinfection was associated with an increased relative hazard (adjusted hazard ratio [HR] [95% confidence interval; CI]) of hip fracture, compared to HCV-monoinfected (HR, 1.38; 95% CI: 1.25-1.53), HIV-monoinfected (females: HR, 1.76; 95% CI: 1.44-2.16; males: HR, 1.36; 95% CI: 1.20-1.55), and HCV/HIV-uninfected persons (females: HR, 2.65; 95% CI: 2.21-3.17; males: HR, 2.20; 95% CI: 1.97-2.47). HCV monoinfection was associated with an increased risk of hip fracture, compared to uninfected individuals, and the relative increase was highest in the youngest age groups (females, 18-39 years: HR, 3.56; 95% CI: 2.93-4.32; males, 18-39 years: HR, 2.40; 95% CI: 2.02-2.84).
Among Medicaid enrollees, HCV/HIV coinfection was associated with increased rates of hip fracture, compared to HCV-monoinfected, HIV-monoinfected, and HCV/HIV-uninfected persons. HCV-monoinfected patients had an increased risk of hip fracture, compared to uninfected individuals.
本研究旨在确定单纯丙型肝炎病毒(HCV)感染与未感染个体相比,是否会增加髋部骨折的风险,并探讨HCV/人类免疫缺陷病毒(HIV)合并感染患者与单纯 HCV 感染、单纯 HIV 感染以及未感染两种病毒的个体相比,其髋部骨折风险是否更高。
我们在美国加利福尼亚州、佛罗里达州、纽约州、俄亥俄州和宾夕法尼亚州的 Medicaid 人群中开展了一项队列研究,纳入了 36950 例 HCV/HIV 合并感染、276901 例 HCV 单纯感染、95827 例 HIV 单纯感染和 3110904 例 HCV/HIV 未感染患者(1999-2005 年)。髋部骨折发生率在未感染者中最低(1.29 例/1000 人年),随着 HIV 感染(1.95 例/1000 人年)或 HCV 感染(2.69 例/1000 人年)的存在而增加,在 HCV/HIV 合并感染患者中最高(3.06 例/1000 人年)。
与 HCV 单纯感染相比,HCV/HIV 合并感染与髋部骨折的相对危险度(校正后危险比[HR] [95%置信区间; CI])增加(HR,1.38;95%CI:1.25-1.53),与 HIV 单纯感染(女性:HR,1.76;95%CI:1.44-2.16;男性:HR,1.36;95%CI:1.20-1.55)和 HCV/HIV 未感染个体(女性:HR,2.65;95%CI:2.21-3.17;男性:HR,2.20;95%CI:1.97-2.47)相比。与未感染者相比,HCV 单纯感染也与髋部骨折风险增加相关,且风险增加在年龄最小的人群中最高(女性,18-39 岁:HR,3.56;95%CI:2.93-4.32;男性,18-39 岁:HR,2.40;95%CI:2.02-2.84)。
在 Medicaid 参保者中,与 HCV 单纯感染、HIV 单纯感染和 HCV/HIV 未感染个体相比,HCV/HIV 合并感染与髋部骨折发生率增加相关。与未感染者相比,HCV 单纯感染患者髋部骨折风险增加。